
England’s health service to stop prescribing puberty blockers to transgender kids
CNN
England’s National Health Service (NHS) has stopped prescribing puberty blockers for children and young people with gender dysphoria or gender incongruence, saying there is “not enough evidence to support the safety or clinical effectiveness” of puberty-suppressing hormones.
England’s National Health Service (NHS) has stopped prescribing puberty blockers for children and young people with gender dysphoria or gender incongruence, saying there is “not enough evidence to support the safety or clinical effectiveness” of puberty-suppressing hormones. NHS England said it made the decision, which was widely condemned by LGBTQ groups, after it “carefully considered” an evidence review it commissioned in 2020. It also reviewed evidence published since then, it said in a policy document published Tuesday. Puberty blockers will now only be available to young people in clinical research trials and some private clinics, UK’s PA Media reported Tuesday. Fewer than 100 young people are currently on puberty blockers via the NHS and they will be able to continue the treatment, it added. Puberty blockers will also available through some private gender identity clinics. According to the NHS clinical policy, treatment for young people “focuses on psychosocial and psychological support.” Gender-affirming hormones and surgery may be available later or in adulthood. Gender-affirming care for young people in England has faced legal and political scrutiny in recent years that has coincided with rising anti-trans rhetoric in the country, say LGBTQ advocates.

The two men killed as they floated holding onto their capsized boat in a secondary strike against a suspected drug vessel in early September did not appear to have radio or other communications devices, the top military official overseeing the strike told lawmakers on Thursday, according to two sources with direct knowledge of his congressional briefings.












